These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 11705752)
41. Colonic motor function in humans is not affected by gender. Soffer EE; Kongara K; Achkar JP; Gannon J Dig Dis Sci; 2000 Jul; 45(7):1281-4. PubMed ID: 10961704 [TBL] [Abstract][Full Text] [Related]
42. Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans. Manabe N; Camilleri M; Rao A; Wong BS; Burton D; Busciglio I; Zinsmeister AR; Haruma K Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G970-5. PubMed ID: 20378829 [TBL] [Abstract][Full Text] [Related]
43. Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation. Iturrino J; Camilleri M; Wong BS; Linker Nord SJ; Burton D; Zinsmeister AR Aliment Pharmacol Ther; 2013 Apr; 37(8):776-85. PubMed ID: 23451764 [TBL] [Abstract][Full Text] [Related]
44. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome. Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; MÃ¥nsson M; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769 [TBL] [Abstract][Full Text] [Related]
45. Effect of different doses of erythromycin on colonic motility in patients with slow transit constipation. Bassotti G; Chiarioni G; Vantini I; Morelli A; Whitehead WE Z Gastroenterol; 1998 Mar; 36(3):209-13. PubMed ID: 9577904 [TBL] [Abstract][Full Text] [Related]
46. Sensations of gas and pain and their relationship with compliance during distension in human colon. Iturrino J; Camilleri M; Busciglio I; Burton D; Zinsmeister AR Neurogastroenterol Motil; 2012 Jul; 24(7):646-51, e275. PubMed ID: 22393902 [TBL] [Abstract][Full Text] [Related]
47. Differential regional effects of octreotide on human gastrointestinal motor function. von der Ohe MR; Camilleri M; Thomforde GM; Klee GG Gut; 1995 May; 36(5):743-8. PubMed ID: 7797125 [TBL] [Abstract][Full Text] [Related]
48. Effect of neurotensin on colorectal motor and sensory function in humans. van der Veek PP; Schots ED; Masclee AA Dis Colon Rectum; 2004 Feb; 47(2):210-8. PubMed ID: 15043292 [TBL] [Abstract][Full Text] [Related]
49. Effects of a meal and bisacodyl on colonic motility in healthy volunteers and patients with slow-transit constipation. De Schryver AM; Samsom M; Smout AI Dig Dis Sci; 2003 Jul; 48(7):1206-12. PubMed ID: 12870774 [TBL] [Abstract][Full Text] [Related]
50. Opposite effects on human distal colon motility of two postulated alpha 2-antagonists (mianserin and chlorprothixene) and one alpha 2-agonist (clonidine). Lechin F; van der Dijs B J Clin Pharmacol; 1983; 23(5-6):209-18. PubMed ID: 6875022 [TBL] [Abstract][Full Text] [Related]
51. Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transit. Appel S; Kumle A; Meier R Clin Pharmacol Ther; 1997 Nov; 62(5):546-55. PubMed ID: 9390111 [TBL] [Abstract][Full Text] [Related]
52. Pharmacogenetics of low dose clonidine in irritable bowel syndrome. Camilleri M; Busciglio I; Carlson P; McKinzie S; Burton D; Baxter K; Ryks M; Zinsmeister AR Neurogastroenterol Motil; 2009 Apr; 21(4):399-410. PubMed ID: 19309415 [TBL] [Abstract][Full Text] [Related]
53. Effect of cholecystokinin on rectal motor and sensory function in patients with irritable bowel syndrome and healthy controls. van der Schaar PJ; van Hoboken E; Ludidi S; Masclee AA Colorectal Dis; 2013 Jan; 15(1):e29-34. PubMed ID: 23006632 [TBL] [Abstract][Full Text] [Related]
54. Effect of pinaverium bromide on jejunal motility and colonic transit time in healthy humans. Bouchoucha M; Salles JP; Fallet M; Frileux P; Cugnenc PH; Barbier JP Biomed Pharmacother; 1992; 46(4):161-5. PubMed ID: 1421047 [TBL] [Abstract][Full Text] [Related]
55. Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation. Camilleri M; Carlson P; McKinzie S; Grudell A; Busciglio I; Burton D; Baxter K; Ryks M; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G13-9. PubMed ID: 17962356 [TBL] [Abstract][Full Text] [Related]
56. Control of muscle tone in the human colon. Steadman CJ; Phillips SF; Camilleri M; Talley NJ; Haddad A; Hanson R Gut; 1992 Apr; 33(4):541-6. PubMed ID: 1582599 [TBL] [Abstract][Full Text] [Related]
57. Characterization of two models of drug-induced constipation in mice and evaluation of mustard oil in these models. Kojima R; Doihara H; Nozawa K; Kawabata-Shoda E; Yokoyama T; Ito H Pharmacology; 2009; 84(4):227-33. PubMed ID: 19752586 [TBL] [Abstract][Full Text] [Related]
58. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health. Grudell AB; Camilleri M; Jensen KL; Foxx-Orenstein AE; Burton DD; Ryks MD; Baxter KL; Cox DS; Dukes GE; Kelleher DL; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1114-9. PubMed ID: 18372395 [TBL] [Abstract][Full Text] [Related]
59. Gastrointestinal transit in mice treated with various extracts of date (Phoenix dactylifera L.). Al-Qarawi AA; Ali BH; Al-Mougy SA; Mousa HM Food Chem Toxicol; 2003 Jan; 41(1):37-9. PubMed ID: 12453726 [TBL] [Abstract][Full Text] [Related]
60. Disturbed colonic motility contributes to anorectal symptoms and dysfunction after radiotherapy for carcinoma of the prostate. Yeoh EK; Bartholomeusz DL; Holloway RH; Fraser RJ; Botten R; Di Matteo A; Moore JW; Schoeman MN Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):773-80. PubMed ID: 20153122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]